163 results on '"Monopoli, Angela"'
Search Results
2. A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice
3. Nitric Oxide Release Combined with Nonsteroidal Antiinflammatory Activity Prevents Muscular Dystrophy Pathology and Enhances Stem Cell Therapy
4. Biologic Activity of Adenosine A2a Receptor Antagonists
5. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties
6. Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice
7. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis
8. Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices
9. Sensitivity to selective adenosine A 1 and A 2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices
10. Striatal Outflow of Adenosine, Excitatory Amino Acids, γ-Aminobutyric Acid, and Taurine in Awake Freely Moving Rats After Middle Cerebral Artery Occlusion: Correlations With Neurological Deficit and Histopathological Damage
11. Nonsteroidal Anti-Inflammatory Drugs Increase Tumor Necrosis Factor Production in the Periphery but Not in the Central Nervous System in Mice and Rats
12. 5-Hydroxytryptamine induces contraction in isolated human mammary artery: Effect of ketanserin
13. A β-carboline antagonizes benzodiazepine actions but does not precipitate the abstinence syndrome in cats
14. Production of leukotrienes in a model of focal cerebral ischaemia in the rat
15. Treatment with a Nitric Oxide-Donating NSAID Alleviates Functional Muscle Ischemia in the Mouse Model of Duchenne Muscular Dystrophy
16. Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A 2A receptor antagonists
17. Nitric oxide prevents atorvastatin‐induced skeletal muscle dysfunction and alterations in mice
18. Treatment with a nitric oxide‐donating NSAID counteracts functional muscle ischemia in dystrophin‐deficient mdx mice
19. Gastrointestinal Profile and Efficacy in Rats of the Cyclooxygenase-Inhibiting Nitric Oxide Donator (CINOD) Compound NCX 429
20. The Cyclooxygenase-Inhibiting Nitric Oxide Donator (CINOD) Compound NCX 429 Exhibits Reduced Gastrointestinal Toxicity as Compared with Naproxen in Arthritic and Aspirin-Treated Rats
21. ChemInform Abstract: Selective Adenosine A2A Receptor Antagonists
22. The cardio-protective properties of NCX-6550, a nitric oxide donating pravastatin, in the mouse
23. NCX 4040, a Nitric Oxide-Donating Aspirin, Exerts Anti-Inflammatory Effects through Inhibition of IκB-α Degradation in Human Monocytes
24. 3 H-[1,2,4]-Triazolo[5,1- i]purin-5-amine derivatives as adenosine A 2A antagonists
25. Potent, selective, and orally active adenosine A 2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3- e]-1,2,4-triazolo[1,5- c]pyrimidines
26. Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists
27. Potent, selective, and orally active adenosine A2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
28. 3H-[1,2,4]-Triazolo[5,1-i]purin-5-amine derivatives as adenosine A2A antagonists
29. Nitric Oxide–Releasing Aspirin Derivative, NCX 4016, Promotes Reparative Angiogenesis and Prevents Apoptosis and Oxidative Stress in a Mouse Model of Peripheral Ischemia
30. The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat
31. Nonsteroidal Anti-Inflammatory Drugs Increase Tumor Necrosis Factor Production in the Periphery but Not in the Central Nervous System in Mice and Rats
32. Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes
33. Effects of A1 and A2A adenosine receptor ligands in mouse acute models of pain
34. Persistent Behavioral Sensitization to Chronic l-DOPA Requires A2AAdenosine Receptors
35. 7-Substituted 5-Amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A Adenosine Receptor Antagonists: A Study on the Importance of Modifications at the Side Chain on the Activity and Solubility
36. Production of leukotrienes in a model of focal cerebral ischaemia in the rat
37. Selective adenosine A2A receptor antagonists
38. Dual actions of A2A adenosine receptor antagonists on motor dysfunction and neurodegenerative processes
39. Design, Radiosynthesis, and Biodistribution of a New Potent and Selective Ligand for in Vivo Imaging of the Adenosine A2A Receptor System Using Positron Emission Tomography
40. Adenosine receptors in neurological disorders
41. Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression
42. Formation and pharmacological modulation of leukotrienes in a model of focal cerebral ischemia in the rat
43. Role of A2A Receptor in the Modulation of Myocardial Reperfusion Damage
44. Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats
45. A 2A -Adenosine Receptor Reserve for Coronary Vasodilation
46. Mechanism and Pressor Relevance of the Short-Term Cardiovascular and Renin Excitatory Actions of the Selective A2A-Adenosine Receptor Agonists
47. PROLONGED EXPOSURE TO 5′-N-ETHYLCARBOXAMIDOADENOSINE (NECA) DOES NOT AFFECT THE ADENOSINE A2A-MEDIATED VASODILATION IN PORCINE CORONARY ARTERIES
48. CARDIOPROTECTIVE EFFECTS OF ADENOSINE A1AND A2ARECEPTOR AGONISTS IN THE ISOLATED RAT HEART
49. HEMODYNAMIC CHANGES DO NOT MEDIATE THE CARDIOPROTECTION INDUCED BY THE A1, ADENOSINE RECEPTOR AGONIST CCPA IN THE RABBIT
50. Binding of the Novel Nonxanthine A 2A Adenosine Receptor Antagonist [ 3 H]SCH58261 to Coronary Artery Membranes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.